Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Christine Leopold"'
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Public health care payer organizations face increasing pressures to make transparent and sustainable coverage decisions about ever more expensive prescription drugs, suggesting a need for public engagement in coverage decisions. H
Externí odkaz:
https://doaj.org/article/8ec39ee8f3054c5aa5530827810257de
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-17 (2019)
PURPOSE: The population of Chile has aged, and in 2017, cancer became the leading cause of death. Since 2005, a national health program has expanded coverage of drugs for 13 types of cancer and related palliative care. We describe the trends in publi
Externí odkaz:
https://doaj.org/article/8252bd322bd74a14824fecee8182b544
Autor:
Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing
Publikováno v:
Bulletin of the World Health Organization, Vol 92, Iss 9, Pp 630-640 (2014)
Objective To identify pharmaceutical policy changes during the economic recession in eight European countries and to determine whether policy measures resulted in lower sales of, and less expenditure on, pharmaceuticals. Methods Information on pharma
Externí odkaz:
https://doaj.org/article/0b891f917dda4eda8ffdf391758f1f06
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 8, Iss sup1 (2015)
Externí odkaz:
https://doaj.org/article/816ea9c6e8a34337a6cc8dc31a8c5cf4
Publikováno v:
Journal of Law, Medicine & Ethics. 48:538-551
Over the past decades, anti-cancer treatments have evolved rapidly from cytotoxic chemotherapies to targeted therapies including oral targeted medications and injectable immunooncology and cell therapies. New anti-cancer medications come to markets a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97264f68f36700c86b7934f20df9c364
https://doi.org/10.1177/1073110520958879
https://doi.org/10.1177/1073110520958879
Publikováno v:
Health Policy and Planning
Nearly 2 billion people globally have no access to essential medicines. This means essential medicines are unavailable, unaffordable, inaccessible, unacceptable or of low quality for more than a quarter of the population worldwide. This supplement de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ba50604121ed4df45059f49ceb04fa
https://doi.org/10.1093/heapol/czz119
https://doi.org/10.1093/heapol/czz119
Publikováno v:
PharmacoEconomics Open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157a504ad8bb90b6798065824d53a911
https://doi.org/10.1007/s41669-019-0170-z
https://doi.org/10.1007/s41669-019-0170-z
Autor:
Anita K. Wagner, Craig C. Earle, Christine Y. Lu, Dennis Ross-Degnan, J. Frank Wharam, Fang Zhang, Christine Leopold, Larissa Nekhlyudov
Publikováno v:
Breast Cancer Research and Treatment. 171:449-459
High-deductible health plan (HDHP) enrollment is expanding rapidly and might substantially increase out-of-pocket (OOP) payment burden. We examined trends in total and OOP health service expenditures overall and by insurance coverage type among women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d9f13d63ef9deeb8822eeb29ae01ea2
https://doi.org/10.1007/s10549-018-4819-6
https://doi.org/10.1007/s10549-018-4819-6
Publikováno v:
JNCI: Journal of the National Cancer Institute. 110:699-703
Because of the rising costs of cancer care and ongoing challenges in ensuring access to quality care, there is an increasing need to prioritize spending and define the benefits of therapy in proportion to costs. The term "value" has gained favor as m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20b8ba02b3e8db754043a4acb87f18f
https://doi.org/10.1093/jnci/djy079
https://doi.org/10.1093/jnci/djy079
Publikováno v:
Canadian Medical Association Journal. 189:E794-E799
BACKGROUND: Managing expenditures on pharmaceuticals is important for health systems to sustain universal access to necessary medicines. We sought to estimate the size and sources of differences in expenditures on primary care medications among high-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4196d1a326a722f57391f3139fcb8e2d
https://doi.org/10.1503/cmaj.161481
https://doi.org/10.1503/cmaj.161481